Pay-for-delay cases belong in-house at FTC, not in federal court, Ohlhausen says


The following article first appeared on April 20 on MLex. For more information on MLex, including getting access to its exclusive content, please contact sales@mlex.com. The Federal Trade Commission should use its in-house courts to hear pay-for-delay lawsuits against drug companies, not federal courts that have "struggled" to